A prominent feature of B-CLL cells is the strong correlation of UGT2B17 expression with the adverse marker ZAP70 encoding a tyrosine kinase that promotes B-CLL cell survival. This evidence concerns the gene ZAP70 and B-cell chronic lymphocytic leukemia.